Answers are grounded in this paper and cite their sources.
Review discusses aging effects on β cell regeneration in diabetes, suggesting implications for therapies.
Preservation and regeneration of β cell endocrine function is a long-sought goal in diabetes research. Defective insulin secretion from β cells underlies both type 1 and type 2 diabetes, thus fueling considerable interest in molecules capable of rebuilding β cell secretion capacity. Though early work in rodents suggested that regeneration might be possible, recent studies have revealed that aging powerfully restricts cell cycle entry of β cells, which may limit regeneration capacity. Consequently, aging has emerged as an enigmatic challenge that might limit β cell regeneration therapies. This Review summarizes recent data regarding the role of aging in β cell regeneration and proposes models explaining these phenomena.
No takes yet. Share an insight, caveat, or question.
Jake A. Kushner (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: